In Other News

• Researchers Developing 'Lab-in-Box' Kit for Medium Throughput Processing of COVID-19 Samples for Detection Using RT-PCR

• Fujirebio Europe Partners with Centogene to Provide Rapid and High-Quality Preventive SARS-CoV-2 Antigen Testing

• PerkinElmer’s EUROIMMUN Launches Anti-SARS-CoV-2 QuantiVac ELISA (IgG) to Measure IgG Antibodies Against SARS-CoV-2 S1 Antigen

• Antibodies Created During Infection with Common Cold Coronaviruses Can Also Target SARS-CoV-2

• Study Offers Insight into Designing COVID-19 Drugs to Dually Inhibit SARS-CoV-2 Entry and Replication

• FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection

• Nasal Antiviral Spray That Blocks Transmission of SARS-CoV-2 in Ferrets Could Halt Spread of COVID-19

• Regeneron to Continue Trial Evaluating Antibody Cocktail REGN-COV2 in Hospitalized COVID-19 Patients

• Carolina Liquid Chemistries COVID-19 Antibody Test Receives FDA EUA for Use with Fingerstick Blood Samples at POC

• AI System Distinguish COVID-19 from Flu and Other Respiratory Diseases in Less Than Three Seconds

• AstraZeneca COVID-19 Vaccine Could Be Ready for Large-Scale Immunization as Early as December, Says CEO

• Highly Automated Microlab Half the Size of Credit Card Detects COVID-19 in 30 Minutes

• Rapid Changes in Inflammation Biomarker Could Be Key Predictor of COVID-19 Outcomes

• COVID-19 Antigen Tests for Rapid Detection of SARS-CoV-2 Can Provide False Positive Results, Warns FDA

• New Bacterial Delivery System to Administer COVID-19 Vaccine Directly to Respiratory Tract as Nasal Spray

• Statins Reduces Mortality by 22% to 25% in COVID-19 Patients

• COVID-19 Test Uses DNA Nanoswitch Technology to Detect SARS-CoV-2 Virus

• Scientists Discover Fastest Way to Identify Potent, Neutralizing Human Monoclonal Antibodies Against SARS-CoV-2

• Free Artificial Intelligence Software for Rapid Detection of COVID-19 from CT Scans Launched Globally

• ORAcollect RNA Saliva Collection Device for SARS CoV-2 Granted FDA Emergency Use Authorization

• Nasally Administered Drug Could Generate Nasal Mucosal Immunity Against SARS-CoV-2

• Fujifilm Launches Droplet-Reduction Mouthpiece to Reduce COVID-19 Risk in Endoscopic Examinations

• Artificial Intelligence Algorithm Analyzes Chest X-Rays to Detect COVID-19 in Seconds